vicriviroc

Related by string. Vicriviroc * * *

Related by context. All words. (Click for frequent words.) 73 APTIVUS r 73 pomalidomide 73 raltegravir 72 PREZISTA r 72 ISENTRESS 72 darunavir 72 Aptivus 71 APTIVUS 71 elotuzumab 71 ritonavir boosted 71 INTELENCE 70 temsirolimus 70 iniparib 69 posaconazole 69 nitazoxanide 69 celgosivir 69 tipranavir 69 lapatinib Tykerb 69 PEG Interferon lambda 69 teriflunomide 69 BAY #-# 69 mapatumumab 69 virologic failure 69 boosted protease inhibitor 69 axitinib 68 Reverset 68 TMC# [001] 68 rilpivirine 68 phase IIb 68 valopicitabine 68 bicifadine 68 cabazitaxel 68 vandetanib 68 forodesine 68 LEXIVA r 68 tenofovir emtricitabine 68 enfuvirtide 68 CCR5 antagonist 68 maraviroc 68 NRTI 68 NATRECOR R 68 peginterferon alfa 2b 67 PegIntron 67 RRMS patients 67 INCB# [001] 67 abatacept 67 decitabine 67 CANCIDAS 67 NRTIs 67 desvenlafaxine succinate 67 Viramidine 67 cilengitide 67 sunitinib malate 67 Dasatinib 67 NNRTIs 67 tanespimycin 67 active comparator 67 adalimumab 67 cediranib 67 REYATAZ R 67 NOXAFIL 67 pertuzumab 67 sorafenib Nexavar 67 sapacitabine 67 LY# [003] 67 atrasentan 67 HGS# 67 protease inhibitor PI 67 febuxostat 67 low dose cytarabine 67 AZT zidovudine Retrovir 67 Targretin 67 mycophenolate mofetil 67 Taxotere ® 67 figitumumab 66 docetaxel chemotherapy 66 genotypic resistance 66 lamivudine 66 atazanavir 66 abiraterone acetate 66 neratinib 66 MIRCERA 66 dosage regimens 66 integrase inhibitor 66 nelfinavir 66 glatiramer acetate 66 abacavir 66 lopinavir ritonavir 66 TMC# r 66 darunavir ritonavir 66 Fludara 66 bosutinib 66 protease inhibitor 66 tasocitinib 66 bendamustine 66 ganetespib 66 cangrelor 66 Aptivus ® 66 sunitinib 66 tipranavir r 66 eltrombopag 66 fosamprenavir 66 HCV SPRINT 66 ritonavir boosted atazanavir 66 motesanib 66 pegylated interferon alpha 66 tocilizumab 66 Torisel 66 phase IIb clinical 66 ustekinumab 66 abacavir lamivudine 66 ixabepilone 66 peginterferon 66 Phase Ib clinical 66 SCH # 66 PREZISTA rtv 65 CCR5 inhibitor 65 GAMMAGARD 65 3TC lamivudine Epivir 65 PROMACTA 65 CIMZIA TM 65 ZOLINZA 65 docetaxel Taxotere R 65 Jevtana 65 adefovir 65 dose cohort 65 ramipril 65 fluvastatin 65 REVLIMID ® 65 sitagliptin 65 μg dose 65 enzastaurin 65 dasatinib 65 mg BID 65 LAF# 65 telbivudine 65 mg kg dose 65 mg dose 65 antiviral efficacy 65 Selzentry 65 atazanavir sulfate 65 tamsulosin 65 Zolinza 65 TDF FTC 65 lopinavir r 65 DAPT 65 AEGR 65 phase IIb trial 65 adalimumab Humira 65 pegylated interferons 65 dose cohorts 65 canakinumab 65 BENICAR HCT 65 investigational protease inhibitor 65 oral ridaforolimus 65 QVA# 65 Epivir 65 valsartan 65 pazopanib 65 virological failure 65 tigecycline 65 TELCYTA 65 sorafenib 65 uric acid lowering 65 regorafenib 65 LEXIVA 65 palonosetron 65 trastuzumab emtansine T DM1 65 romidepsin 65 Betaferon ® 65 JANUVIA 65 rNAPc2 65 ancrod 65 visilizumab 65 sustained virologic response 65 Traficet EN 65 HGS ETR1 65 sargramostim 65 insulin detemir 65 atazanavir ritonavir 65 aflibercept 65 oral rivaroxaban 64 lesinurad 64 Roche Pegasys 64 entecavir 64 antiretroviral naive 64 alpha 2a 64 Phase 1b trial 64 dose escalation 64 Dacogen injection 64 obatoclax 64 romiplostim 64 protease inhibitors PIs 64 PEG SN# 64 Velcade bortezomib 64 Laquinimod 64 LY# [002] 64 apremilast 64 rosuvastatin 64 Amrubicin 64 dose regimens 64 refractory CLL 64 ZD# [001] 64 evaluating tivozanib 64 NVA# 64 lintuzumab 64 etravirine 64 alvespimycin 64 mg QD 64 cobicistat 64 albinterferon alfa 2b 64 galiximab 64 dacetuzumab 64 COPEGUS 64 XmAb# 64 Mipomersen 64 VIRAMUNE 64 MAGE A3 ASCI 64 ezetimibe simvastatin 64 INTEGRILIN 64 ticagrelor 64 BCX# 64 Tarceva TM 64 SELZENTRY 64 Asentar 64 #mg dose [001] 64 Doxil 64 interferon alfa 64 Darunavir 64 nilotinib 64 Phenoptin 64 TORISEL 64 nucleoside analog 64 phase Ib 64 FTY# 64 Panzem R NCD 64 MERLIN TIMI 64 mRCC 64 monotherapy 64 infusional 5-FU/LV 64 Pemetrexed 64 trastuzumab Herceptin R 64 ascending dose 64 irbesartan 64 nucleoside analogues 64 carboplatin paclitaxel 64 FOLFOX 64 blinded randomized placebo controlled 64 favorable pharmacokinetic profile 64 crizotinib PF # 64 CR# vcMMAE 64 budesonide foam 64 relapsed MM 64 elvitegravir 64 desvenlafaxine 64 Vicriviroc 64 efavirenz EFV 64 RSD# oral 64 saquinavir ritonavir 64 mitoxantrone 64 dosing regimens 64 boceprevir 64 octreotide LAR 64 TBC# 64 azacitidine 64 DOXIL 64 ocrelizumab 64 clodronate 64 lasofoxifene 64 adecatumumab 64 LPV r 64 Elotuzumab 64 telcagepant 64 fenofibric acid 64 ritonavir boosted lopinavir 64 Ophena TM 63 motavizumab 63 daclizumab 63 HuMax EGFr 63 Pegintron 63 maximally tolerated dose 63 azilsartan medoxomil 63 mg doses 63 phase IIa 63 YONDELIS 63 rilonacept 63 cART 63 baminercept 63 ibandronate 63 double blinded placebo 63 YERVOY 63 mcg dose 63 AEG# 63 abiraterone 63 lixisenatide 63 gemcitabine Gemzar 63 Femara letrozole 63 lopinavir 63 urocortin 2 63 ritonavir boosted protease inhibitor 63 HuLuc# 63 pharmacodynamics PD 63 stavudine d4T 63 placebo controlled Phase 63 Phase 2b clinical 63 alfa 2a 63 Tekamlo 63 ziprasidone 63 nucleoside analogue 63 custirsen 63 vildagliptin 63 metaglidasen 63 Pegasys R 63 antithrombotics 63 gefitinib 63 registrational trial 63 Revlimid lenalidomide 63 safinamide 63 dosing cohorts 63 placebo controlled clinical 63 thymalfasin 63 Peg IFN 63 ZACTIMA 63 bezafibrate 63 aflibercept VEGF Trap 63 Plicera 63 weekly subcutaneous injections 63 tenofovir Viread 63 RLAI 63 peginterferon alfa 2a 63 mcg kg 63 S/GSK# 63 Cloretazine 63 APPRAISE 63 Phase 2a trial 63 PROSTVAC TM 63 RoACTEMRA 63 #mg BID [003] 63 sorafenib tablets 63 dapagliflozin 63 BRIM2 63 Rebif ® 63 nucleoside reverse transcriptase inhibitor 63 chlorambucil 63 BARACLUDE R 63 ribavirin RBV 63 pharmacokinetics PK 63 NNRTI 63 MYCAMINE 63 oral deforolimus 63 antiretroviral regimen 63 tasimelteon 63 Mylotarg 63 pioglitazone 63 viral kinetics 63 dutasteride 63 amprenavir 63 elagolix 63 glufosfamide 63 tofacitinib 63 goserelin 63 DU #b 63 LUX Lung 63 Phase #/#a 63 peginterferon alfa 63 oral FTY# 63 fostamatinib 63 virologic 63 HCV RESPOND 2 63 antiepileptic drug 63 pegylated liposomal doxorubicin 63 EOquin 63 divalproex sodium 63 JAK inhibitor 63 EVIZON 63 cariprazine 63 pegylated interferon alfa 2a 63 mcg doses 63 mipomersen 63 tiotropium 63 Taxotere R 63 anti leukemic 63 gefitinib Iressa 63 Noxafil 63 Pegasys plus Copegus 63 efavirenz Sustiva 63 dacarbazine 63 ASA# 63 paricalcitol 63 FOLFOX4 63 thalidomide Thalomid 63 peginterferon alpha 2a 62 dabigatran etexilate 62 PRISTIQ 62 SIMPONI 62 candesartan 62 L BLP# 62 efalizumab 62 ELOXATIN 62 Prezista 62 Tyrima 62 Pertuzumab 62 APTIVUS ritonavir 62 Pazopanib 62 Boceprevir 62 odanacatib 62 telaprevir dosed 62 3TC 62 lenalidomide dexamethasone 62 pharmacokinetic interactions 62 tecarfarin 62 Eltrombopag 62 trastuzumab Herceptin ® 62 paclitaxel Taxol ® 62 paliperidone ER 62 randomized multicenter Phase III 62 Teriflunomide 62 nalbuphine ER 62 PXD# 62 phase IIa clinical 62 darapladib 62 Temsirolimus 62 nab paclitaxel 62 daunorubicin 62 edoxaban 62 Phase 1b clinical 62 vorinostat 62 alvimopan 62 Phase Ib study 62 NEVO ™ 62 Copegus ribavirin 62 dose escalation phase 62 RG# [001] 62 GSK# [001] 62 bosentan 62 PRT# 62 Phase 2b study 62 TPI ASM8 62 Sym# 62 erlotinib 62 muraglitazar 62 prasugrel Effient 62 pradefovir 62 Kivexa 62 PRADAXA 62 Aurexis 62 clevidipine 62 ruboxistaurin 62 laquinimod 62 CYPHER Stent 62 Erlotinib 62 COMBIVIR 62 certolizumab 62 aleglitazar 62 vinorelbine 62 dexamethasone Decadron 62 placebo dexamethasone 62 golimumab 62 nevirapine Viramune 62 MGd 62 bevirimat 62 LATUDA 62 multicenter Phase II 62 velafermin 62 #mg dose [002] 62 FOLFIRI 62 ularitide 62 TYKERB 62 Maraviroc 62 Pegasys peginterferon alfa 2a 62 Blinatumomab 62 placebo controlled clinical trials 62 RGB # 62 Phase Ib II 62 docetaxel Taxotere 62 mg RDEA# 62 Raltegravir 62 peg IFN 62 NUVIGIL 62 elvucitabine 62 Eloxatin R 62 olaparib 62 SPRYCEL ® 62 panitumumab Vectibix 62 low dose ritonavir 62 pyrazinamide 62 VELCADE melphalan 62 protease inhibitors 62 ACTEMRA TM 62 Focalin XR 62 NXL# 62 pimozide 62 interferon alfa 2b 62 SUTENT 62 DCCR 62 tolerability 62 standard chemotherapy regimen 62 exenatide 62 administered subcutaneously 62 Golimumab 62 myopathy rhabdomyolysis 62 placebo controlled trials 62 HMG CoA reductase inhibitors 62 tolvaptan 62 tenofovir disoproxil fumarate 62 urate lowering 62 plus dexamethasone 62 doxorubicin docetaxel 62 iclaprim 62 zoledronic acid 62 AZILECT 62 Capesaris 62 aclidinium 62 5-FU/LV 62 palifosfamide 62 nucleoside reverse transcriptase inhibitors 62 BEXXAR 62 talabostat 62 otamixaban 62 docetaxel Taxotere ® 62 brivaracetam 62 Vectibix 62 corticosteroid dexamethasone 62 Tanespimycin 62 sitagliptin Januvia 62 zolmitriptan 62 sipuleucel T 62 TELINTRA 62 sirolimus 62 olmesartan 62 seliciclib 62 ZYBRESTAT 62 IFN α 62 gemifloxacin 62 PDE4 inhibitor 62 antiplatelet agent 62 Gabapentin GR 62 ACZ# 62 placebo controlled studies 62 bortezomib 62 ipilimumab 62 BMS # 62 EDEMA3 62 Ceplene/IL-2 62 Phase 1a clinical 62 interferon gamma 1b 62 ISTODAX 62 pemetrexed 62 d4T 62 Sprycel dasatinib 62 oral methylnaltrexone 62 anidulafungin 62 amrubicin 62 HGS ETR2 62 rapid virologic response 62 insulin glargine 62 REMICADE ® 62 subcutaneously administered 62 IRESSA 62 Abacavir 62 Afatinib 62 Promacta 62 Seliciclib 62 virologic response 62 diabetic neuropathic pain 61 delafloxacin 61 etanercept 61 Betaferon R 61 bevacizumab Avastin 61 Phase Ib 61 BRIM3 61 HIV RNA 61 Omnitarg 61 ROTATEQ 61 telmisartan 61 bicalutamide 61 clopidogrel Plavix 61 avosentan 61 Doxil ® 61 idraparinux 61 radezolid 61 comparator arm 61 Xyotax 61 alicaforsen enema 61 fulvestrant 61 Hycamtin 61 NSABP C 61 peg interferon 61 Virulizin ® 61 VAPRISOL 61 anakinra 61 OncoVEX GM CSF 61 Imprime PGG 61 PRECiSE 61 R#/MEM # 61 XL# SAR# 61 alkylating agent 61 Elitek 61 CA4P 61 calcineurin inhibitors 61 idarubicin 61 NNRTI resistance 61 KRN# 61 nucleotide analogue 61 pharmacodynamic properties 61 AGILECT R 61 Roche Xeloda 61 FROVA 61 Vandetanib 61 BARACLUDE ® 61 TACI Ig 61 CLARITY study 61 pramlintide 61 Amplimexon 61 pegylated interferon 61 GVAX 61 dose escalation trial 61 IMGN# 61 benazepril 61 refractory gout 61 cannabinor 61 linagliptin 61 Dabigatran etexilate 61 atorvastatin Lipitor 61 leflunomide 61 peginterferon alfa 2a Pegasys 61 AZILECT R 61 zoledronate 61 aspirin clopidogrel 61 DEB# 61 HBeAg positive patients 61 apricitabine 61 systemically administered 61 pimecrolimus 61 antihypertensive drugs 61 tolerability profiles 61 PREZISTA ritonavir 61 ORENCIA ® 61 treatment naive genotype 61 SRT# [003] 61 prazosin 61 Pegasys ® 61 caspofungin 61 HAART regimens 61 deforolimus 61 nucleoside 61 Dr. McHutchison 61 PSMA ADC 61 Bezielle 61 CoFactor 61 antiretroviral agents 61 GSK# [002] 61 FOSRENOL R 61 HuMax CD4 61 KAPIDEX 61 peginterferon ribavirin 61 GAMMAGARD LIQUID 61 rFVIIa 61 ORENCIA R 61 platelet inhibitor 61 PSN# [002] 61 HER2 positive metastatic breast 61 Dapagliflozin 61 Ixempra 61 voriconazole 61 lipid lowering therapy 61 ofatumumab 61 telaprevir VX 61 Genasense 61 oral prodrug 61 methylnaltrexone 61 interferon ribavirin 61 taribavirin 61 teriparatide 61 levosimendan 61 rifabutin 61 Tolvaptan 61 STELARA 61 KRAS status 61 HQK 61 pegylated interferon alfa 2b 61 natalizumab 61 Xelox 61 Tekturna HCT 61 cobiprostone 61 oxaliplatin Eloxatin 61 Atacand 61 micafungin 61 ribavirin Copegus 61 lumiliximab 61 adefovir dipivoxil 61 angiotensin receptor blocker ARB 61 Symadex 61 atazanavir Reyataz 61 Phase IIIb clinical 61 ramelteon 61 ULORIC 61 aripiprazole 61 Nexavar ® 61 certolizumab pegol 61 Atrasentan 61 Engerix B 61 CBLC# 61 insulin degludec 61 randomized Phase IIb 61 aliskiren 61 therapeutic regimens 61 metastatic castration resistant 61 HCD# [002] 61 inhibitor RG# 61 antithrombotic 61 cilostazol 61 viral kinetic 61 ongoing Phase 1b 61 pramlintide metreleptin combination 61 FOLFOX6 chemotherapy regimen 61 Proleukin 61 PS# [001] 61 comparator PI r 61 bortezomib Velcade 61 HBeAg negative 61 degarelix 61 #mg/day [001] 61 flutamide 61 zidovudine lamivudine 61 ZYVOX 61 Vfend 61 achieved statistical significance 61 VPRIV 61 indinavir 61 gemcitabine 61 INVIRASE 61 #mg BID [001] 61 PEGylated interferon beta 1a 61 steroid dexamethasone 61 Intelence 61 AVASTIN 61 #mg/m# [001] 61 virologic responses 61 virus HCV protease inhibitor 61 riociguat 61 Darusentan 61 receptor tyrosine kinase inhibitor 61 Arranon 61 omalizumab 61 clobazam 61 Leukine 61 #I TM# 61 Lamivudine 61 levetiracetam 61 dosing intervals 61 FUZEON 61 PEG INTRON 61 EndoTAGTM 1 61 vemurafenib 61 ximelagatran 61 concomitant medications 61 antiplatelet therapy 61 Genz # 61 enoximone 61 NATRECOR ® 61 tirofiban 61 ARCOXIA 61 investigational monoclonal antibody 61 trabedersen 61 Xinlay 61 midstage clinical 61 aripiprazole Abilify 61 pegloticase 61 Aflibercept 61 MAXY alpha 61 rosuvastatin Crestor 61 dose cytarabine 61 quetiapine 61 ToGA 61 rHuPH# 61 NPH insulin 61 IV bisphosphonates 61 lacosamide 61 paclitaxel Taxol 61 gadobutrol 61 novel oral anticoagulant 61 Durezol 61 Yervoy 61 subcutaneous formulation 61 non nucleoside reverse 61 TYGACIL 61 anastrozole 61 Linagliptin 61 DermaVir Patch 61 rindopepimut 61 Hepsera 61 Apixaban 61 esomeprazole 61 allopurinol 61 Nasacort AQ 61 formoterol fumarate 61 dose regimen 61 Pegylated interferon 61 ascending doses 61 retapamulin 61 Prosaptide 61 alpha 2b 61 Ambrisentan 61 eprotirome 61 TMC# C# 61 randomized Phase III 61 BRAF inhibitor 61 CHOP chemotherapy 61 IFN beta 61 Phase IIb trials 61 Natalizumab 61 HBeAg seroconversion 61 tipifarnib 61 pegylated interferon alfa 61 selective modulator 61 viral suppression 61 TREDAPTIVE 61 ambrisentan 61 ARB telmisartan 61 Zalbin 61 EDARBI 61 Technosphere Insulin 60 ritonavir 60 ezetimibe 60 milligram dose 60 prucalopride 60 melphalan prednisone 60 mg/# hr 60 ARIMIDEX 60 docetaxel 60 Celsentri Selzentry 60 piperacillin tazobactam 60 etanercept Enbrel 60 beta2 agonist 60 trastuzumab 60 nucleotide analog 60 antihypertensive agents 60 tolterodine 60 intermittent dosing 60 blinatumomab 60 non nucleoside HCV 60 R# #mg BID 60 Cytoxan 60 Celebrex celecoxib 60 coadministration 60 tapentadol IR 60 Octreolin 60 perampanel 60 ddI 60 Sustiva efavirenz 60 FOLPI 60 mg/m2 dose 60 EndoTAG TM -1 60 ATACAND 60 Cethromycin 60 metastatic hormone refractory 60 Aliskiren 60 Cloretazine R VNP#M 60 phase IIb study 60 Treanda 60 pravastatin 60 trastuzumab DM1 T DM1 60 tesmilifene 60 donepezil 60 erlotinib Tarceva 60 REYATAZ ® 60 mGluR5 NAM 60 ABC/3TC 60 Multaq R 60 Tipranavir 60 darunavir r 60 AIM HIGH 60 Dose escalation 60 Clonicel 60 Tasigna nilotinib 60 randomized #:#:# 60 ARCALYST 60 ISIS # 60 afatinib 60 montelukast 60 Heplisav 60 risedronate 60 glatiramer 60 Apoptone 60 Copegus 60 Pafuramidine 60 tremelimumab 60 Aromasin 60 epoetin beta 60 THALOMID 60 pramipexole 60 ponatinib 60 EOquin TM 60 virologic suppression 60 IDX# 60 saquinavir 60 metastatic HRPC 60 Xanafide 60 Vaprisol 60 CIMZIA ™ 60 Interferon alpha 60 MAA submission 60 Clolar 60 AVE# 60 alemtuzumab Campath 60 glucose lowering 60 DPP4 inhibitor 60 timolol 60 MoxDuo TM IR 60 Phase IIa trial 60 LCP AtorFen 60 elesclomol 60 unfractionated heparin 60 PEGINTRON TM 60 estramustine 60 plus prednisone prednisolone 60 LymphoStat B 60 CDP# 60 CRx 60 gemcitabine chemotherapy 60 thromboembolic events 60 zileuton 60 Telintra 60 Diovan HCT 60 CCR5 tropic HIV 60 angiogenesis inhibitor 60 baseline HbA1c 60 Letairis 60 transcriptase inhibitor NNRTI 60 PREZISTA 60 placebo controlled Phase III 60 candesartan cilexetil 60 budesonide 60 Proellex TM 60 faropenem 60 gemcitabine carboplatin 60 fibrate 60 experienced virologic failure 60 IMA# 60 Phase 2b trial 60 sitaxsentan 60 panitumumab 60 risperidone Risperdal 60 inecalcitol 60 PEG INTRON R 60 plus prednisone 60 nucleoside polymerase inhibitor 60 AZILECT ® 60 interferon alfa 2a 60 daptomycin 60 adipiplon 60 intravenous bisphosphonates 60 Taxol paclitaxel 60 leucovorin 60 aprepitant 60 CsA 60 SERMs 60 #mg doses [002] 60 Muraglitazar 60 IIIa inhibitor 60 direct thrombin inhibitors 60 SYMBICORT 60 relapsed myeloma 60 rifapentine 60 bazedoxifene 60 eplerenone 60 Sanofi Aventis Taxotere 60 abatacept Orencia 60 phase IIIb 60 thienopyridines 60 moxifloxacin 60 Sitagliptin 60 Xeloda ® 60 refractory AML 60 Azedra 60 lupus nephritis 60 SEROQUEL XR 60 Fibrillex TM 60 QTc prolongation 60 AZD# 60 ALVESCO 60 antiretroviral naïve 60 imetelstat 60 Gleevec imatinib 60 mepolizumab 60 Q#IR 60 pioglitazone HCl 60 SAR# [004] 60 Phase 1b 60 REYATAZ 60 JANUMET 60 OMS# 60 eptifibatide 60 intensive lipid lowering 60 heavily pretreated 60 Starlix 60 prospectively defined 60 IGF 1R inhibitor

Back to home page